|
| 37536582 | Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer. | | 2023 |
| 36017622 | Urinary Outcomes After Magnetic Resonance Imaging-Guided Whole-Gland Transurethral Ultrasound Ablation for Prostate Cancer: Comparison of Suprapubic Tube to Indwelling Urethral Catheter. | Journal of Endourology | 2023 |
| 36073925 | Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance. | J Urol | 2023 |
| 37805052 | Effect of Transperineal Versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men Prior to Radiation Therapy for Prostate Cancer. | | 2023 |
| 37722985 | Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification. | Urol Oncol | 2023 |
| 36517408 | A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance. | Eur Urol Focus | 2023 |
| 36653280 | Longitudinal analysis of YouTube videos discussing post-prostatectomy erectile dysfunction. | Urol Oncol | 2023 |
| 37208135 | Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications. | BMJ Open | 2023 |
| 37139610 | Editorial Comment. | | 2023 |
| 37012549 | Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial. | Nat Med | 2023 |
| 36564278 | Re: Randomized Trial of Ultralow vs Standard Pneumoperitoneum during Robotic Prostatectomy. | | 2023 |
| 37042826 | Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer. | | 2023 |
| 34993496 | Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. | HGG Adv | 2022 |
| 36284002 | Association of nerve-sparing grading in robotic radical prostatectomy and trifecta outcome. | World Journal of Urology | 2022 |
| 36008253 | Differential changes in self-reported quality of life in elderly populations after diagnosis of a genitourinary malignancy. | Urol Oncol | 2022 |
| 35881781 | Reply by Authors. | J Urol | 2022 |
| 35478055 | Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer. | Med Oncol | 2022 |
| 35984102 | Lost in Transparency: The 21st Century Cures Act ("Open Notes") and Prostate Cancer Care. | Journal of Urology | 2022 |
| 34146124 | New imaging modalities to consider for men with prostate cancer on active surveillance. | World Journal of Urology | 2022 |
| 33439577 | Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society. | Minerva Urol Nephrol | 2022 |
| 34344628 | Using Competing Risk of Mortality to Inform the Transition from Prostate Cancer Active Surveillance to Watchful Waiting. | Eur Urol Focus | 2022 |
| 34857445 | Patient and in-hospital predictors of post-discharge opioid utilization: Individualizing prescribing after radical prostatectomy based on the ORIOLES initiative. | Urologic Oncology: Seminars and Original Investigations | 2022 |
| 35238838 | The role of genetic testing in prostate cancer screening, diagnosis, and treatment. | Curr Opin Oncol | 2022 |
| 35347252 | Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. | Prostate Cancer Prostatic Dis | 2022 |
| 34503355 | Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort. | J Urol | 2021 |
| 32115400 | Cost-effectiveness Analysis of Tc-sestamibi SPECT/CT to Guide Management of Small Renal Masses. | European Urology Focus | 2021 |
| 33972702 | What level of evidence will it take to move towards widespread adoption of transperineal prostate biopsy in the USA? | Prostate Cancer and Prostatic Diseases | 2021 |
| 33487007 | Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance. | J Urol | 2021 |
| 34107778 | Evidence-Based Recommendations for Opioid Prescribing After Endourological and Minimally Invasive Urological Surgery. | Journal of Endourology | 2021 |
| 33617332 | Specific Detection of Prostate Cancer Cells in Urine by RNA In Situ Hybridization. | J Urol | 2021 |
| 34043339 | Rapid Diagnosis of Prostate Cancer Disease Progression Using Paper Spray Ionization Mass Spectrometry. | Analytical Chemistry | 2021 |
| 34195392 | Perirectal hydrogel spacer placement prior to prostate radiation therapy using a probe-mounted needle guide. | Clinical and Translational Radiation Oncology | 2021 |
| 32654363 | Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trial. | BJU Int | 2021 |
| 32820256 | A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridization. | Prostate Cancer Prostatic Dis | 2021 |
| 32929627 | A prospective comparative study of routine versus deferred pelvic drain placement after radical prostatectomy: impact on complications and opioid use. | World J Urol | 2021 |
| 33355501 | Reply by Authors. | J Urol | 2021 |
| 32731747 | A Comparative Analysis of Surgical Scar Cosmesis Based on Operative Approach for Radical Prostatectomy. | J Endourol | 2021 |
| 32948433 | Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey. | Urol Oncol | 2021 |
| 33432182 | Surgical ergonomics for urologists: a practical guide. | Nat Rev Urol | 2021 |
| 32524295 | Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer. | Med Oncol | 2020 |
| 35474889 | A multi-institutional randomized controlled trial comparing first-generation transrectal high-resolution micro-ultrasound with conventional frequency transrectal ultrasound for prostate biopsy. | BJUI Compass | 2020 |
| 31643128 | Effect of a prospective opioid reduction intervention on opioid prescribing and use after radical prostatectomy: results of the Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES) Initiative. | BJU International | 2020 |
| 32367635 | Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance. | BJU Int | 2020 |
| 32111915 | Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery. | Sci Rep | 2020 |
| 31923397 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2020 |
| 32444264 | Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. | Eur Urol | 2020 |
| 32031685 | Downgrading of grade group 2 intermediate-risk prostate cancer from biopsy to radical prostatectomy: Comparison of outcomes and predictors to identify potential candidates for active surveillance. | Cancer | 2020 |
| 30826221 | Re: Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial. | | 2019 |
| 37300091 | Identifying Current Trends in the Urologic Oncology Workforce-Does Completion of Fellowship Significantly Change Future Practice? | | 2019 |
| 31675502 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2019 |